Polypodium Leucotomos.

Ascorbate quenches aqueous-phase radicals in the dermis and regenerates oxidised vitamin E at the membrane, the same radical load polypodium phenolics act on after light exposure. The oral vitamin C and E pairing is the photoprotective base a polypodium extract sits on.

Alpha tocopherol sits in the lipid bilayer and stops lipid peroxidation chains that light exposure starts, a compartment the water-soluble polypodium phenolics reach poorly. The two cover the aqueous and lipid halves of the same defence.

Astaxanthin spans the membrane and is an efficient singlet oxygen quencher, the species most generated by UVA in skin lipids. Polypodium acts more on DNA damage signalling and matrix enzyme expression, so the mechanisms do not overlap.

Nicotinamide restores cellular NAD after light exposure, which keeps PARP-dependent DNA repair running in keratinocytes. Polypodium reduces the initial oxidative and photoproduct load, so one lowers the damage and the other supports repair.

Lycopene accumulates in skin and raises the erythema threshold by quenching singlet oxygen in the lipid phase. It works in a different compartment from polypodium's polyphenol action.

Beta carotene deposits in the stratum corneum and subcutaneous fat and quenches singlet oxygen generated by UVA. It works in a compartment and by a mechanism distinct from polypodium's phenolic antioxidants.

Pine bark procyanidins reduce matrix metalloproteinase expression and support dermal microcirculation, close to the pathways polypodium acts on but from a different phenolic class. The two broaden the phenolic coverage.

EGCG lowers UV-induced cyclobutane pyrimidine dimer formation and dampens the inflammatory cascade in keratinocytes. That overlaps with polypodium's action on the same signalling but through a separate catechin chemistry.

Lutein and its isomer accumulate in skin and absorb in the blue and near-UV band, filtering light before it generates radicals. Polypodium works on the downstream damage response instead of filtering.

Collagen peptides supply glycine and proline rich fragments and signal dermal fibroblasts to raise matrix output. Polypodium acts on the matrix-degrading enzyme side, so one limits breakdown while the other feeds rebuilding.

Zeaxanthin accumulates in skin tissue after oral intake and absorbs light at wavelengths that overlap the shorter visible range. A polyphenol-rich fern extract acts mainly on the radical chemistry that follows absorption rather than on the light itself. The two therefore sit at different points of the same sequence, which is why they appear together in oral skin formulas.

Ubiquinol terminates lipid peroxidation chains inside membranes, a compartment water-soluble phenolics reach poorly. The fern extract's phenolic acids act in the aqueous phase. Covering both compartments is the standard rationale for pairing them, and it rests on where each molecule sits rather than on a joint trial.

Glutathione is the dominant intracellular thiol buffer in skin cells and is consumed when reactive species accumulate after light exposure. Phenolic antioxidants intercept radicals before that pool is drawn down. The relationship is compartmental and mechanistic; oral glutathione's own absorption is a separate question.

Cysteine availability is the rate-limiting input to glutathione synthesis, and N-acetylcysteine supplies it. That supports the intracellular thiol pool the fern extract's phenolics work alongside. This is settled pathway biochemistry, not a combination that has been tested together.

Dihydrolipoic acid is unusual in being active in both water and lipid environments, and it returns other antioxidants to their reduced state. Phenolic radicals from an extract can in principle be recycled rather than consumed. The mechanism is described in redox chemistry; no shared clinical data is being cited.

Resveratrol and the fern's cinnamic acid derivatives are both phenolics that scavenge radicals and modulate stress-response signalling in keratinocytes. Formulators combine them for breadth of structure rather than for a demonstrated additive effect. The pairing is convention supported by shared chemistry.

Sulforaphane is a well-characterised activator of the NRF2 pathway, which raises expression of the cell's own antioxidant and phase II enzymes. That is an induced, longer-lasting defence sitting alongside the direct scavenging a phenolic extract provides. The two act on different timescales, which is the substance of the pairing.

Skin makes vitamin D only when UVB reaches the epidermis, so anything that changes sun behaviour also changes that input. An oral photoprotective agent is often used by people who are also limiting deliberate sun exposure. Formulators pair the two on that logic; it is a behavioural and biochemical interaction rather than a direct chemical one.

Hyaluronic acid is used for dermal water-binding, an entirely different axis from radical chemistry. The two appear in the same capsules because they address separate aspects of normal skin structure. No shared mechanism is being claimed, and the pairing is a formulation choice.

EPA and DHA are incorporated into membrane phospholipids and shift the substrate mix available to cyclooxygenase and lipoxygenase enzymes. That is a membrane-composition effect rather than radical scavenging. The two lines of action are independent, which is why the combination is common in skin-directed formulas.

Tocotrienols insert into membranes and interrupt lipid peroxidation chains, with an unsaturated tail that distributes differently from tocopherol. Water-soluble phenolics cannot reach that compartment. The pairing covers two physical environments rather than duplicating one.

Ceramides are structural lipids of the outermost skin layer and relate to barrier integrity, not to radical chemistry. Oral formulas combine them with antioxidant extracts to address structure and oxidative load together. The rationale is compositional and the two do not interact chemically.

Glutathione peroxidase and thioredoxin reductase are selenoproteins, so selenium status sets the ceiling on the enzymatic side of peroxide handling in skin. Plant phenolics act non-enzymatically. Adequate selenium is a precondition for one arm of the system rather than an additive antioxidant in its own right.